State of Wisconsin Investment Board’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.84M Buy
99,141
+28,684
+41% +$1M 0.01% 1213
2026
Q1
$2.71M Sell
70,457
-3,769
-5% -$139K 0.01% 1282
2025
Q4
$2.64M Sell
74,226
-21,667
-23% -$609K 0.01% 1303
2025
Q3
$1.38M Sell
95,893
-106,096
-53% -$1.26M ﹤0.01% 1493
2025
Q2
$1.45M Buy
201,989
+37,776
+23% +$209K ﹤0.01% 1432
2025
Q1
$984K Buy
164,213
+101,176
+161% +$793K ﹤0.01% 1492
2024
Q4
$492K Buy
63,037
+15,327
+32% +$153K ﹤0.01% 1830
2024
Q3
$515K Sell
47,710
-11,685
-20% -$114K ﹤0.01% 1862
2024
Q2
$501K Buy
59,395
+33,968
+134% +$258K ﹤0.01% 1821
2024
Q1
$171K Sell
25,427
-2,442
-9% -$15.1K ﹤0.01% 2091
2023
Q4
$164K Sell
27,869
-11,605
-29% -$88.9K ﹤0.01% 2230
2023
Q3
$385K Buy
39,474
+10,573
+37% +$125K ﹤0.01% 1935
2023
Q2
$342K Sell
28,901
-1,028
-3% -$11.8K ﹤0.01% 1952
2023
Q1
$323K Sell
29,929
-2,973
-9% -$38K ﹤0.01% 2060
2022
Q4
$380K Buy
+32,902
New +$408K ﹤0.01% 2013
2019
Q2
Sell
-6,475
Closed -$114K 1549
2019
Q1
$114K Buy
+6,475
New +$111K ﹤0.01% 1498

Other funds holding COGT

State of Wisconsin Investment Board's COGT Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Cogent Biosciences (COGT) stake by 41% in Q2 2026, buying an estimated $1M and bringing the position to 99,141 shares worth $3.84M. The position accounts for 0.01% of the portfolio, ranked #1213.

State of Wisconsin Investment Board first reported a position in COGT in Q1 2019 and has held it in 16 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • State of Wisconsin Investment Board held 99,141 shares of Cogent Biosciences worth $3.84M as of Q2 2026.
  • State of Wisconsin Investment Board bought 28,684 Cogent Biosciences shares in Q2 2026, an estimated $1M.
  • Cogent Biosciences made up 0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1213 holding.
  • State of Wisconsin Investment Board first reported a position in Cogent Biosciences in Q1 2019 and has held it in 16 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.